Endonovo Closes Asset Purchase Agreement for a Minimum of $50M With SofPulse, Inc
Los Angeles, CA, March 28, 2024 (GLOBE NEWSWIRE) — Endonovo (OTC PINK: ENDV) and its subsidiary, SofPulse, Inc., today announced they have finalized and completed the Asset Purchase Agreement (APA), originally signed in December 2023, for the acquisition of Endonovo’s assets and Intellectual Property (IP) for a minimum of $50 million.
Related news for (ENDV)
- Endonovo’s SofPulse® to Be Featured at Innovative Pain Management Solutions
- Endonovo Signs Definitive Agreement to Sell SofPulse® Brand Business and IP to SofPulse Inc. for a minimum of $50 Million
- Endonovo’s SofPulse® Secures Taiwan FDA Approval
- Endonovo’s SofPulse® Secures Federal Supply Schedule Inclusion to Accelerate Expansion of VA Distribution